CDKN1A and breast carcinoma: SA inhibited the cell cycle at the G1 and G2 phases, increased cell cycle inhibitor p21CIP1/WAF1 and p27KIP1 levels, and decreased cyclin-dependent kinase 2 (CDK2) phosphorylation in Hs578T human breast cancer cells.